Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Clinical and Electroencephalographic Correlations with Serum Levels of Diphenylhydantoin
1960 • 277 citations
Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses
1975 • 187 citations
Carbamazepine for epilepsy
1974 • 185 citations
Anticonvulsant Effect of Diphenylhydantoin Relative to Plasma Levels
1974 • 184 citations
Tic Douloureux Treated With New Anticonvulsant
1963 • 102 citations
Mass Spectrometric Characterization of Carbamazepine-10,11-epoxide,a Carbamazepine Metabolite Isolated from Human Urine
1972 • 82 citations
Some Causes of Ineffectiveness of Diphenylhydantoin
1966 • 75 citations
Carbamazepine plasma and tissue levels in the rat
1971 • 59 citations
Preliminary observations of serum carbamazepine concentration in epileptic patients
1973 • 58 citations
Quantitative determination of carbamazepine in plasma by mass fragmentography
1973 • 58 citations
Tegretol (Carbamazepine): A Controlled Trial of a New Anti-Convulsant
1966 • 55 citations
Methods of Analysis of Antiepileptic Drugs
1974 • 54 citations
Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatography
1975 • 51 citations
Concentration of Carbamazepine (Tegretol®) in Serum and in Cerebrospinal Fluid in Patients with Epilepsy
1973 • 37 citations
Methods of Analysis of Anti-Epileptic Drugs
1974 • 34 citations